Diana Rodijk-Olthuis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Diana Rodijk-Olthuis has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ellen H. van Den Bogaard
Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands
7 shared publications - Ivonne M. J. J. van Vlijmen‐Willems
Department of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
5 shared publications - Joost Schalkwijk
Department of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
5 shared publications - Patrick L. J. M. Zeeuwen
Department of Dermatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands
5 shared publications - Gijs Rikken
Dermatology, Radboudumc, Nijmegen, Netherlands
4 shared publications - Hanna Niehues
Department of Dermatology, Radboudumc, Nijmegen, The Netherlands
4 shared publications
Latest Publications
- 6 May 2024
- Published by Wiley in Experimental Dermatology
- Vol. 33 (5) , e15084
CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders
The transmembrane protein claudin‐1 is critical for formation of the epidermal barrier structure called tight junctions (TJ) and has been shown to be important in multiple disease states. These include neonatal ichthyosis and sclerosing cholangitis syndrome, atopic dermatitis and various viral infections. To develop a model to investigate the role of claudin‐1 in different disease settings, we used CRISPR/Cas9 to generate human immortalized keratinocyte (KC) lines lacking claudin‐1 (CLDN1 KO). We then determined whether loss of claudin‐1 expression affects epidermal barrier formation/function and KC differentiation/stratification. The absence of claudin‐1 resulted in significantly reduced barrier function in both monolayer and organotypic cultures. CLDN1 KO cells demonstrated decreases in gene transcripts encoding the barrier protein filaggrin and the differentiation marker cytokeratin‐10. Marked morphological differences were also observed in CLDN1 KO organotypic cultures including diminished stratification and reduced formation of the stratum granulosum. We also detected increased proliferative KC in the basale layer of CLDN1 KO organotypic cultures. These results further support the role of claudin‐1 in epidermal barrier and suggest an additional role of this protein in appropriate stratification of the epidermis.
- 6 May 2024
- Published by Wiley in Experimental Dermatology
- Vol. 33 (5) , e15084
CLDN1 knock out keratinocytes as a model to investigate multiple skin disorders
The transmembrane protein claudin‐1 is critical for formation of the epidermal barrier structure called tight junctions (TJ) and has been shown to be important in multiple disease states. These include neonatal ichthyosis and sclerosing cholangitis syndrome, atopic dermatitis and various viral infections. To develop a model to investigate the role of claudin‐1 in different disease settings, we used CRISPR/Cas9 to generate human immortalized keratinocyte (KC) lines lacking claudin‐1 (CLDN1 KO). We then determined whether loss of claudin‐1 expression affects epidermal barrier formation/function and KC differentiation/stratification. The absence of claudin‐1 resulted in significantly reduced barrier function in both monolayer and organotypic cultures. CLDN1 KO cells demonstrated decreases in gene transcripts encoding the barrier protein filaggrin and the differentiation marker cytokeratin‐10. Marked morphological differences were also observed in CLDN1 KO organotypic cultures including diminished stratification and reduced formation of the stratum granulosum. We also detected increased proliferative KC in the basale layer of CLDN1 KO organotypic cultures. These results further support the role of claudin‐1 in epidermal barrier and suggest an additional role of this protein in appropriate stratification of the epidermis.
- 22 February 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2013-2028.e2
The Aryl Hydrocarbon Receptor Regulates Epidermal Differentiation through Transient Activation of TFAP2A
- 22 February 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2013-2028.e2
The Aryl Hydrocarbon Receptor Regulates Epidermal Differentiation through Transient Activation of TFAP2A
- Open Access
The aryl hydrocarbon receptor regulates epidermal differentiation through transient activation of TFAP2A
The aryl hydrocarbon receptor (AHR) is an evolutionary conserved environmental sensor identified as indispensable regulator of epithelial homeostasis and barrier organ function. Molecular signaling cascade and target genes upon AHR activation and their contribution to cell and tissue function are however not fully understood. Multi-omics analyses using human skin keratinocytes revealed that, upon ligand activation, AHR binds open chromatin to induce expression of transcription factors (TFs), e.g., Transcription Factor AP-2α (TFAP2A), as a swift response to environmental stimuli. The terminal differentiation program including upregulation of barrier genes, filaggrin and keratins, was mediated by TFAP2A as a secondary response to AHR activation. The role of AHR-TFAP2A axis in controlling keratinocyte terminal differentiation for proper barrier formation was further confirmed using CRISPR/Cas9 in human epidermal equivalents. Overall, the study provides novel insights into the molecular mechanism behind AHR-mediated barrier function and potential novel targets for the treatment of skin barrier diseases.
Open AccessThe aryl hydrocarbon receptor regulates epidermal differentiation through transient activation of TFAP2A
The aryl hydrocarbon receptor (AHR) is an evolutionary conserved environmental sensor identified as indispensable regulator of epithelial homeostasis and barrier organ function. Molecular signaling cascade and target genes upon AHR activation and their contribution to cell and tissue function are however not fully understood. Multi-omics analyses using human skin keratinocytes revealed that, upon ligand activation, AHR binds open chromatin to induce expression of transcription factors (TFs), e.g., Transcription Factor AP-2α (TFAP2A), as a swift response to environmental stimuli. The terminal differentiation program including upregulation of barrier genes, filaggrin and keratins, was mediated by TFAP2A as a secondary response to AHR activation. The role of AHR-TFAP2A axis in controlling keratinocyte terminal differentiation for proper barrier formation was further confirmed using CRISPR/Cas9 in human epidermal equivalents. Overall, the study provides novel insights into the molecular mechanism behind AHR-mediated barrier function and potential novel targets for the treatment of skin barrier diseases.
- Open Access
- 7 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1520-1528.e5
Investigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes
- 7 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (8) , 1520-1528.e5
Open AccessInvestigations into the FLG Null Phenotype: Showcasing the Methodology for CRISPR/Cas9 Editing of Human Keratinocytes
- 23 September 2022
- Published by Morressier GmbH
ESDR195 - Untangling the complex cytokine milieu in psoriasis and atopic dermatitis through organotypic epidermal models
In psoriasis (PSO) and atopic dermatitis (AD), the complex inflammatory milieu drives epidermal disease hallmarks that are associated to skin inf | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR195 - Untangling the complex cytokine milieu in psoriasis and atopic dermatitis through organotypic epidermal models
In psoriasis (PSO) and atopic dermatitis (AD), the complex inflammatory milieu drives epidermal disease hallmarks that are associated to skin inf | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR196 - Aryl hydrocarbon receptor ligand leflunomide exerts triple action to dampen the inflammatory skin disease atopic dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which patients suffer from red, itching skin lesions. Current therapeutics targe | POSTER
- 23 September 2022
- Published by Morressier GmbH
ESDR196 - Aryl hydrocarbon receptor ligand leflunomide exerts triple action to dampen the inflammatory skin disease atopic dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease in which patients suffer from red, itching skin lesions. Current therapeutics targe | POSTER
- Open Access
- 22 October 2021
- Published by Elsevier in JID Innovations
- Vol. 2 (1) , 100066
Identification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
- 22 October 2021
- Published by Elsevier in JID Innovations
- Vol. 2 (1) , 100066
Open AccessIdentification of Keratinocyte Mitogens: Implications for Hyperproliferation in Psoriasis and Atopic Dermatitis
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , S168
120 Identification of keratinocyte mitogens: implications for hyperproliferation in psoriasis and atopic dermatitis
- 1 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 141 (10) , S168
120 Identification of keratinocyte mitogens: implications for hyperproliferation in psoriasis and atopic dermatitis